Showing results for "3SBio"
business
Five Stocks to Watch as China Breaks Into Global Drug MarketMany of China’s most innovative drug firms have ambitions to be global leaders in the next generation of medicines for cancer, hepatitis and other diseases. While the industry is still at a nascent stage, more companies are attempting to develop their own blockbuster therapies.September 4, 2018
technology
Road to Chinese Drug Riches Runs Through the Bronx, New JerseyLou Jing earned a Ph.D at Fordham University in the Bronx before completing post-doctoral studies at the National Institutes of Health. Frank Zhang got his from Duke University before heading to New Jersey for a job with Schering-Plough Corp.May 31, 2018
business
3SBio's Tan on Pipeline products, Opportunities, RegulationBo Tan, chief financial officer at 3SBio, discusses the opportunities he's seeing in China's red-hot healthcare sector, the products in the company pipeline, approvals and regulation changes, competition and acquisitions. He speaks exclusively on "Bloomberg Markets: Asia" from the Morgan Stanley China summit in Beijing. (Source: Bloomberg)May 29, 2018